Apollo Medical Devices Receives NIH and NSF Awards to Develop its Portable Blood Analysis System

Apollo Medical Devices Receives NIH and NSF Awards to Develop its Portable Blood Analysis System

ID: 515571

Cleveland company provides single-drop-of-blood, handheld analysis, in 5 minutes


(firmenpresse) - CLEVELAND, OH -- (Marketwired) -- 01/03/17 -- Apollo Medical Devices has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to conduct research and development on its handheld blood analysis system that provides results in five-minutes, using a single drop of blood. Additionally, the company received a National Institutes of Health (NIH) Clinical Facilitation Award for $25,000 through the CIMIT (Consortia for Improving Medicine with Innovation and Technology) Point-of-Care Technology Research Center.

Blood chemistry tests are the most frequently ordered tests in the US. The Apollo technology is minimally invasive, reduces patient fear and discomfort, and reduces costs and errors associated with pre-analytical testing steps. The simple-to-use platform can be utilized in a variety of areas, including neonatal care, acute care centers, first responders, primary care, military care, and disaster relief organizations. The global market for point-of-care blood chemistry testing is estimated to be $3.0 Billion.

"Apollo is extremely excited to receive the support of the NSF and the NIH," said Punkaj Ahuja, Founder and CTO of Apollo Medical Devices. "This funding validates our premise and will be instrumental in moving our technology one step closer to regulatory submission and commercialization."

Apollo Medical Devices, LLC is a medical technology company focused on the development and commercialization of in vitro diagnostics and point-of-care testing. The technology is protected by the Company's issued and pending patents licensed from and invented at Case Western Reserve University in Cleveland, OH. For more information: .

Image Available:



Punkaj Ahuja
Founder and CTO
Phone: (216) 820-8849




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  MEDIA ADVISORY: BMO CEO Bill Downe to Speak at RBC Capital Markets Canadian Bank CEO Conference Freddie Mac Announces Final ACIS Transaction of 2016
Bereitgestellt von Benutzer: Marketwired
Datum: 03.01.2017 - 17:30 Uhr
Sprache: Deutsch
News-ID 515571
Anzahl Zeichen: 0

contact information:
Town:

CLEVELAND, OH



Kategorie:

Commercial & Investment Banking



Diese Pressemitteilung wurde bisher 234 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Apollo Medical Devices Receives NIH and NSF Awards to Develop its Portable Blood Analysis System"
steht unter der journalistisch-redaktionellen Verantwortung von

Apollo Medical Devices (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Apollo Medical Devices



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z